Tirzepatide, a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, has shown promise in the treatment of type 2 diabetes and obesity
Efficacy and safety of oral small molecule glucagon-like peptide 1 receptor agonist danuglipron for glycemic control among patients with Type 2 diabetes: a randomized clinical trial
Circ_0067717 promotes colorectal cancer cell growth, invasion and glutamine metabolism by serving as a mir-497-5p sponge to upregulate slc7a5
& Cole, S
Shi M, Zabetian CP, Hancock AM, Ginghina C, Hong Z, Yearout D, Chung KA, Quinn JF, Peskind ER, Galasko D, Jankovic J, Leverenz JB, Zhang J (2010) Significance and confounders of peripheral DJ-1 and alpha-synuclein in Parkinsons disease
Texture & Feel